98 related articles for article (PubMed ID: 16893070)
21. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice.
Malipiero U; Frei K; Spanaus KS; Agresti C; Lassmann H; Hahne M; Tschopp J; Eugster HP; Fontana A
Eur J Immunol; 1997 Dec; 27(12):3151-60. PubMed ID: 9464800
[TBL] [Abstract][Full Text] [Related]
22. EAE in the common marmoset Callithrix jacchus.
Uccelli A; Giunti D; Capello E; Roccatagliata L; Mancardi GL
Int MS J; 2003 Apr; 10(1):6-12. PubMed ID: 12906764
[TBL] [Abstract][Full Text] [Related]
23. Neurodegeneration in autoimmune CNS inflammation.
Herz J; Zipp F; Siffrin V
Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
[TBL] [Abstract][Full Text] [Related]
24. The complement attack phase: control of lysis and non-lethal effects of C5b-9.
Hänsch GM
Immunopharmacology; 1992; 24(2):107-17. PubMed ID: 1473962
[No Abstract] [Full Text] [Related]
25. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
[TBL] [Abstract][Full Text] [Related]
26. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
Raine CS
Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
[No Abstract] [Full Text] [Related]
27. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
[TBL] [Abstract][Full Text] [Related]
29. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury.
Ren G; Huynh C; Bijian K; Cybulsky AV
Mol Immunol; 2008 Apr; 45(8):2236-46. PubMed ID: 18178252
[TBL] [Abstract][Full Text] [Related]
30. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
Lev N; Barhum Y; Melamed E; Offen D
Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
[TBL] [Abstract][Full Text] [Related]
31. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
[TBL] [Abstract][Full Text] [Related]
32. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Mokhtarian F; Safavi F; Sarafraz-Yazdi E
Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
[TBL] [Abstract][Full Text] [Related]
33. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.
Merkler D; Ernsting T; Kerschensteiner M; Brück W; Stadelmann C
Brain; 2006 Aug; 129(Pt 8):1972-83. PubMed ID: 16714315
[TBL] [Abstract][Full Text] [Related]
34. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
35. Oligodendrocytes: the putative target cells of multiple sclerosis.
Abramsky O
Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
[No Abstract] [Full Text] [Related]
36. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
37. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
Scolding NJ; Morgan BP; Houston WA; Linington C; Campbell AK; Compston DA
Nature; 1989 Jun; 339(6226):620-2. PubMed ID: 2733792
[TBL] [Abstract][Full Text] [Related]
38. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
39. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.
Shriver LP; Dittel BN
Am J Pathol; 2006 Sep; 169(3):999-1011. PubMed ID: 16936273
[TBL] [Abstract][Full Text] [Related]
40. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
